Clinical Trials

Showing 321 - 340 of 485 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of Hypofractionated Stereotactic Radiosurgery with Bevacizumab to Treat Recurrent Malignant Glioma
[Protocol 11-057]
Omuro, Antonio
  • Brain Tumors, Primary
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Combination Chemotherapy with and without Low-Dose Whole-Brain Radiation for Primary Central Nervous System Lymphoma
[Protocol 11-125]
Omuro, Antonio
  • Lymphoma
    • Non-Hodgkin's Lymphoma
  • Pediatric Brain Tumors
    • CNS Cancer
A Study Assessing Varenicline (Chantix) to Treat Tobacco Dependence in Breast Cancer Patients Scheduled for Mastectomy and Reconstructive Surgery
[Protocol 11-136]
Ostroff, Jamie
  • Breast Cancer
  • Tobacco Cessation
A Psychometric Assessment of the Stigma Associated with Lung Cancer
[Protocol 14-012]
Ostroff, Jamie
  • Lung Cancer
Quit IT: Testing of a Web-based Coping Skills Game to Help Smokers Hospitalized for Cancer to Quit Smoking
[Protocol 14-062]
Ostroff, Jamie
  • Tobacco Cessation
A Phase II Study of Dasatinib in Patients with Advanced Non-Small Cell Lung Cancers with DDR2 or Inactivating BRAF Mutations
[Protocol 12-163]
Paik, Paul
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
A Phase I Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancer
[Protocol 11-170]
Paik, Paul
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
A Phase II Study of Ibrutinib plus Rituximab in Patients with Previously Untreated Follicular Lymphoma
[Protocol 14-018]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Rituximab/Lenalidomide or Rituximab/Chemotherapy Followed by Rituximab Maintenance Therapy in Patients with Previously Untreated Follicular Lymphoma
Newly Diagnosed
[Protocol 12-081]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of IMGN529 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
[Protocol 13-073]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of Oral Azacitidine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes after Receiving a Stem Cell Transplant from a Donor
[Protocol 13-160]
Papadopoulos, Esperanza
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of Midostaurin to Prevent Relapse After Allogeneic Stem Cell Transplantation in Patients with FLT3-ITD Mutated Acute Myeloid Leukemia
[Protocol 13-242]
Papadopoulos, Esperanza
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase III Study of CMX001 versus Placebo to Prevent Cytomegalovirus (CMV) Infection in Stem Cell Transplant Recipients Already Exposed to CMV
[Protocol 13-182]
Papanicolaou, Genovefa
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Study of Posaconazole Versus Micafungin to Protect Against Invasive Fungal Infections in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
[Protocol 10-038]
Papanicolaou, Genovefa
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
A Phase II Study Assessing the Effectiveness of a New Vaccine for Preventing Shingles in Patients Who Had an Autologous Stem Cell Transplant
[Protocol 13-054]
Papanicolaou, Genovefa
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
    • Post-Transplant
A Phase III Study of Accelerated Whole Breast Radiation Therapy with a Boost versus Standard Whole Breast Radiation with a Boost in Women with Early-Stage Breast Cancer (RTOG 1005)
[Protocol 12-158]
Parhar, Preeti
  • Breast Cancer
A Phase III Study of Inotuzumab Ozogamicin versus Standard Therapy in Patients with Persistent or Recurrent CD22-Positive Acute Lymphoblastic Leukemia
Relapsed/Refractory
[Protocol 12-262]
Park, Jae
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I/II Study of Low-Dose Cytarabine and Lintuzumab-Ac-225 in Older Patients with Previously Untreated Acute Myeloid Leukemia
Newly Diagnosed
[Protocol 09-053]
Park, Jae
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040]
Park, Jae
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048]
Park, Jae
  • Leukemia
    • Chronic Lymphocytic Leukemia